TWI306152B - - Google Patents

Download PDF

Info

Publication number: TWI306152B
Authority: TW; Taiwan
Prior art keywords: sequence; specific; saccharide; agent; site
Prior art date: 2000-05-05

Application number

TW89108601A

Other languages

English (en)

Chinese (zh)

Inventor

Markman Ofer

Original Assignee

Procognia Israel Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-05

Filing date

2000-05-05

Publication date

2009-02-11

2000-05-05 Application filed by Procognia Israel Ltd filed Critical Procognia Israel Ltd

2000-05-05 Priority to TW89108601A priority Critical patent/TWI306152B/zh

2009-02-11 Application granted granted Critical

2009-02-11 Publication of TWI306152B publication Critical patent/TWI306152B/zh

Links

239000003795 chemical substances by application Substances 0.000 claims description 202
238000000034 method Methods 0.000 claims description 196
235000000346 sugar Nutrition 0.000 claims description 149
150000001720 carbohydrates Chemical class 0.000 claims description 126
238000006243 chemical reaction Methods 0.000 claims description 118
102000005744 Glycoside Hydrolases Human genes 0.000 claims description 97
108010031186 Glycoside Hydrolases Proteins 0.000 claims description 97
108090001090 Lectins Proteins 0.000 claims description 90
102000004856 Lectins Human genes 0.000 claims description 90
239000002523 lectin Substances 0.000 claims description 90
125000000837 carbohydrate group Chemical group 0.000 claims description 45
150000002772 monosaccharides Chemical class 0.000 claims description 43
150000004676 glycans Polymers 0.000 claims description 40
238000004458 analytical method Methods 0.000 claims description 34
239000003814 drug Substances 0.000 claims description 34
229940079593 drug Drugs 0.000 claims description 31
239000000203 mixture Substances 0.000 claims description 31
238000003776 cleavage reaction Methods 0.000 claims description 28
230000007017 scission Effects 0.000 claims description 28
239000012634 fragment Substances 0.000 claims description 26
102000004190 Enzymes Human genes 0.000 claims description 23
108090000790 Enzymes Proteins 0.000 claims description 23
230000027455 binding Effects 0.000 claims description 18
239000000758 substrate Substances 0.000 claims description 16
108700023372 Glycosyltransferases Proteins 0.000 claims description 15
239000007767 bonding agent Substances 0.000 claims description 15
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
239000003153 chemical reaction reagent Substances 0.000 claims description 13
102000051366 Glycosyltransferases Human genes 0.000 claims description 12
239000011324 bead Substances 0.000 claims description 10
235000014633 carbohydrates Nutrition 0.000 claims description 10
150000004804 polysaccharides Polymers 0.000 claims description 10
239000011230 binding agent Substances 0.000 claims description 9
238000005406 washing Methods 0.000 claims description 9
230000003993 interaction Effects 0.000 claims description 8
239000011616 biotin Substances 0.000 claims description 7
229960002685 biotin Drugs 0.000 claims description 7
235000020958 biotin Nutrition 0.000 claims description 7
239000007787 solid Substances 0.000 claims description 7
238000012916 structural analysis Methods 0.000 claims description 7
239000013543 active substance Substances 0.000 claims description 5
239000000427 antigen Substances 0.000 claims description 5
239000000872 buffer Substances 0.000 claims description 5
235000013305 food Nutrition 0.000 claims description 5
230000000873 masking effect Effects 0.000 claims description 5
230000008859 change Effects 0.000 claims description 4
238000011161 development Methods 0.000 claims description 4
238000011049 filling Methods 0.000 claims description 4
230000004913 activation Effects 0.000 claims description 3
238000001994 activation Methods 0.000 claims description 3
238000000354 decomposition reaction Methods 0.000 claims description 3
230000003100 immobilizing effect Effects 0.000 claims description 3
239000003550 marker Substances 0.000 claims description 3
230000009870 specific binding Effects 0.000 claims description 3
238000004040 coloring Methods 0.000 claims description 2
238000010276 construction Methods 0.000 claims description 2
230000003287 optical effect Effects 0.000 claims description 2
FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 2
125000001483 monosaccharide substituent group Chemical group 0.000 claims 2
235000013361 beverage Nutrition 0.000 claims 1
230000004048 modification Effects 0.000 claims 1
238000012986 modification Methods 0.000 claims 1
238000012216 screening Methods 0.000 claims 1
238000002864 sequence alignment Methods 0.000 claims 1
210000002966 serum Anatomy 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 description 37
102000004169 proteins and genes Human genes 0.000 description 36
235000018102 proteins Nutrition 0.000 description 34
229920001282 polysaccharide Polymers 0.000 description 28
239000005017 polysaccharide Substances 0.000 description 28
150000008163 sugars Chemical class 0.000 description 28
150000002482 oligosaccharides Chemical class 0.000 description 24
229940088598 enzyme Drugs 0.000 description 21
229920001542 oligosaccharide Polymers 0.000 description 20
238000001514 detection method Methods 0.000 description 16
238000002372 labelling Methods 0.000 description 15
239000012528 membrane Substances 0.000 description 15
230000002079 cooperative effect Effects 0.000 description 14
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
239000000523 sample Substances 0.000 description 12
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 10
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 10
235000013365 dairy product Nutrition 0.000 description 10
239000002158 endotoxin Substances 0.000 description 10
235000020251 goat milk Nutrition 0.000 description 10
229920006008 lipopolysaccharide Polymers 0.000 description 10
239000000243 solution Substances 0.000 description 10
OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical group CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 9
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 9
238000006722 reduction reaction Methods 0.000 description 9
150000002972 pentoses Chemical class 0.000 description 8
238000007639 printing Methods 0.000 description 8
230000009467 reduction Effects 0.000 description 8
239000000126 substance Substances 0.000 description 8
125000003396 thiol group Chemical group [H]S* 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 7
238000004422 calculation algorithm Methods 0.000 description 7
108090000288 Glycoproteins Proteins 0.000 description 6
102000003886 Glycoproteins Human genes 0.000 description 6
238000005520 cutting process Methods 0.000 description 6
235000013336 milk Nutrition 0.000 description 6
239000008267 milk Substances 0.000 description 6
210000004080 milk Anatomy 0.000 description 6
239000000047 product Substances 0.000 description 6
238000012360 testing method Methods 0.000 description 6
235000012431 wafers Nutrition 0.000 description 6
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 5
229920002683 Glycosaminoglycan Polymers 0.000 description 5
108010061314 alpha-L-Fucosidase Proteins 0.000 description 5
102000012086 alpha-L-Fucosidase Human genes 0.000 description 5
150000001413 amino acids Chemical group 0.000 description 5
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 5
GLNDAGDHSLMOKX-UHFFFAOYSA-N coumarin 120 Chemical compound C1=C(N)C=CC2=C1OC(=O)C=C2C GLNDAGDHSLMOKX-UHFFFAOYSA-N 0.000 description 5
-1 cytokines Chemical class 0.000 description 5
238000010586 diagram Methods 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
229930182830 galactose Natural products 0.000 description 5
239000008103 glucose Substances 0.000 description 5
230000036961 partial effect Effects 0.000 description 5
230000008569 process Effects 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
108010062580 Concanavalin A Proteins 0.000 description 4
229920000855 Fucoidan Polymers 0.000 description 4
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
235000001014 amino acid Nutrition 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000003102 growth factor Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 3
239000004971 Cross linker Substances 0.000 description 3
108090000695 Cytokines Proteins 0.000 description 3
102000004127 Cytokines Human genes 0.000 description 3
108010093031 Galactosidases Proteins 0.000 description 3
102000002464 Galactosidases Human genes 0.000 description 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
229910052791 calcium Inorganic materials 0.000 description 3
239000011575 calcium Substances 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
229960000956 coumarin Drugs 0.000 description 3
235000001671 coumarin Nutrition 0.000 description 3
238000010168 coupling process Methods 0.000 description 3
238000005859 coupling reaction Methods 0.000 description 3
230000005284 excitation Effects 0.000 description 3
239000007850 fluorescent dye Substances 0.000 description 3
102000045442 glycosyltransferase activity proteins Human genes 0.000 description 3
108700014210 glycosyltransferase activity proteins Proteins 0.000 description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
108020004999 messenger RNA Proteins 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
239000012071 phase Substances 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
238000011160 research Methods 0.000 description 3
238000000926 separation method Methods 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
241000894007 species Species 0.000 description 3
230000001954 sterilising effect Effects 0.000 description 3
238000004659 sterilization and disinfection Methods 0.000 description 3
239000013589 supplement Substances 0.000 description 3
238000004809 thin layer chromatography Methods 0.000 description 3
101710186708 Agglutinin Proteins 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
241000252082 Anguilla anguilla Species 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
239000004593 Epoxy Substances 0.000 description 2
229920002971 Heparan sulfate Polymers 0.000 description 2
101710146024 Horcolin Proteins 0.000 description 2
101710189395 Lectin Proteins 0.000 description 2
101710179758 Mannose-specific lectin Proteins 0.000 description 2
101710150763 Mannose-specific lectin 1 Proteins 0.000 description 2
101710150745 Mannose-specific lectin 2 Proteins 0.000 description 2
108010054377 Mannosidases Proteins 0.000 description 2
102000001696 Mannosidases Human genes 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
244000046052 Phaseolus vulgaris Species 0.000 description 2
241000220324 Pyrus Species 0.000 description 2
101100194625 Rattus norvegicus Rgs19 gene Proteins 0.000 description 2
235000004443 Ricinus communis Nutrition 0.000 description 2
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical group [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000009471 action Effects 0.000 description 2
239000000910 agglutinin Substances 0.000 description 2
125000003172 aldehyde group Chemical group 0.000 description 2
150000001299 aldehydes Chemical group 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
239000012491 analyte Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
150000004982 aromatic amines Chemical class 0.000 description 2
238000003556 assay Methods 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
238000004590 computer program Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000008878 coupling Effects 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
230000008034 disappearance Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
230000006870 function Effects 0.000 description 2
238000010230 functional analysis Methods 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
108010090279 galactose permease Proteins 0.000 description 2
FJEKYHHLGZLYAT-FKUIBCNASA-N galp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(O)=O)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C1=CNC=N1 FJEKYHHLGZLYAT-FKUIBCNASA-N 0.000 description 2
239000007789 gas Substances 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
229960002897 heparin Drugs 0.000 description 2
150000002402 hexoses Chemical class 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
238000013507 mapping Methods 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
238000002156 mixing Methods 0.000 description 2
IJTNSXPMYKJZPR-UHFFFAOYSA-N parinaric acid Chemical compound CCC=CC=CC=CC=CCCCCCCCC(O)=O IJTNSXPMYKJZPR-UHFFFAOYSA-N 0.000 description 2
239000002245 particle Substances 0.000 description 2
235000021017 pears Nutrition 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
239000011535 reaction buffer Substances 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
238000009877 rendering Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
229910052725 zinc Inorganic materials 0.000 description 2
239000011701 zinc Substances 0.000 description 2
BOBLSBAZCVBABY-WPWUJOAOSA-N 1,6-diphenylhexatriene Chemical compound C=1C=CC=CC=1\C=C\C=C\C=C\C1=CC=CC=C1 BOBLSBAZCVBABY-WPWUJOAOSA-N 0.000 description 1
JWYUFVNJZUSCSM-UHFFFAOYSA-N 2-aminobenzimidazole Chemical compound C1=CC=C2NC(N)=NC2=C1 JWYUFVNJZUSCSM-UHFFFAOYSA-N 0.000 description 1
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
235000003276 Apios tuberosa Nutrition 0.000 description 1
244000105624 Arachis hypogaea Species 0.000 description 1
235000010777 Arachis hypogaea Nutrition 0.000 description 1
235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
229920001287 Chondroitin sulfate Polymers 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
241000208296 Datura Species 0.000 description 1
229920000045 Dermatan sulfate Polymers 0.000 description 1
108010001394 Disaccharidases Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
240000006212 Erythrina crista-galli Species 0.000 description 1
102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
101150096822 Fuca1 gene Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
108010056771 Glucosidases Proteins 0.000 description 1
102000004366 Glucosidases Human genes 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
108010000540 Hexosaminidases Proteins 0.000 description 1
102000002268 Hexosaminidases Human genes 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
101710197072 Lectin 1 Proteins 0.000 description 1
244000043158 Lens esculenta Species 0.000 description 1
235000010666 Lens esculenta Nutrition 0.000 description 1
241000219822 Macrotyloma axillare Species 0.000 description 1
235000001504 Macrotyloma uniflorum var. uniflorum Nutrition 0.000 description 1
108090000301 Membrane transport proteins Proteins 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
239000004368 Modified starch Substances 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
101000582927 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) Lectin A Proteins 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
240000000528 Ricinus communis Species 0.000 description 1
241000533293 Sesbania emerus Species 0.000 description 1
241000445365 Trypoxylus dichotomus Species 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
240000003864 Ulex europaeus Species 0.000 description 1
235000010730 Ulex europaeus Nutrition 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
235000016127 added sugars Nutrition 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
238000011166 aliquoting Methods 0.000 description 1
108010004469 allophycocyanin Proteins 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
AVJBPWGFOQAPRH-FWMKGIEWSA-N alpha-L-IdopA-(1->3)-beta-D-GalpNAc4S Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C(O)=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-N 0.000 description 1
IJTNSXPMYKJZPR-WVRBZULHSA-N alpha-parinaric acid Natural products CCC=C/C=C/C=C/C=CCCCCCCCC(=O)O IJTNSXPMYKJZPR-WVRBZULHSA-N 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000003491 array Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
KOLXWYUAGBWXOM-UHFFFAOYSA-N butane-1,1-diamine propanoic acid Chemical compound C(CC)(=O)O.C(CCC)(N)N KOLXWYUAGBWXOM-UHFFFAOYSA-N 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
108091008400 carbohydrate binding proteins Proteins 0.000 description 1
102000023852 carbohydrate binding proteins Human genes 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
229940059329 chondroitin sulfate Drugs 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000009194 climbing Effects 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000008094 contradictory effect Effects 0.000 description 1
238000012937 correction Methods 0.000 description 1
125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
229940051593 dermatan sulfate Drugs 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
239000006181 electrochemical material Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
125000003700 epoxy group Chemical group 0.000 description 1
108010014507 erythroagglutinating phytohemagglutinin Proteins 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
150000008195 galaktosides Chemical class 0.000 description 1
244000037671 genetically modified crops Species 0.000 description 1
239000011521 glass Substances 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
238000005858 glycosidation reaction Methods 0.000 description 1
238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
150000002466 imines Chemical class 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000001948 isotopic labelling Methods 0.000 description 1
125000000468 ketone group Chemical group 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
239000002649 leather substitute Substances 0.000 description 1
239000003446 ligand Substances 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000011572 manganese Substances 0.000 description 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
235000019426 modified starch Nutrition 0.000 description 1
238000007479 molecular analysis Methods 0.000 description 1
239000013642 negative control Substances 0.000 description 1
VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
229940046166 oligodeoxynucleotide Drugs 0.000 description 1
238000005457 optimization Methods 0.000 description 1
238000010422 painting Methods 0.000 description 1
244000052769 pathogen Species 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
238000002823 phage display Methods 0.000 description 1
210000003800 pharynx Anatomy 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
238000005554 pickling Methods 0.000 description 1
238000000734 protein sequencing Methods 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000006268 reductive amination reaction Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
229910052707 ruthenium Inorganic materials 0.000 description 1
108010038196 saccharide-binding proteins Proteins 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000000344 soap Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003696 structure analysis method Methods 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

TW89108601A 2000-05-05 2000-05-05 TWI306152B (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
TW89108601A TWI306152B (fr)	2000-05-05	2000-05-05

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
TW89108601A TWI306152B (fr)	2000-05-05	2000-05-05

Publications (1)

Publication Number	Publication Date
TWI306152B true TWI306152B (fr)	2009-02-11

Family

ID=45071313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW89108601A TWI306152B (fr)	2000-05-05	2000-05-05

Country Status (1)

Country	Link
TW (1)	TWI306152B (fr)

2000
- 2000-05-05 TW TW89108601A patent/TWI306152B/zh not_active IP Right Cessation

Legal Events

Date	Code	Title	Description
2014-11-11	MM4A	Annulment or lapse of patent due to non-payment of fees

Publication	Publication Date	Title
JP4988889B2 (ja)	2012-08-01	多糖類の構造および配列決定
US20080182282A1 (en)	2008-07-31	Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same
Chen et al.	2007	Analysis of cell surface carbohydrate expression patterns in normal and tumorigenic human breast cell lines using lectin arrays
JP2002544485A5 (fr)	2010-05-27
US20120277116A1 (en)	2012-11-01	Disease diagnosis according to saccharide binding
US7132251B1 (en)	2006-11-07	Method and composition for analyzing a carbohydrate polymer
CA2428150C (fr)	2012-03-13	Methodes pour analyse comparative de polymeres d'hydrates de carbone
US7056678B1 (en)	2006-06-06	Polysaccharide structure and sequence determination
JP2006523300A (ja)	2006-10-12	リソソーム蓄積症（ｌｄｓ）の多重スクリーニング
TWI306152B (fr)	2009-02-11
CA2407272A1 (fr)	2001-11-08	Procede et composition permettant d'analyser un polymere glucidique
US20060172339A1 (en)	2006-08-03	Particle-based multiplex assay for identifying glycosylation
AU2002225992B2 (en)	2007-03-08	Methods for comparitive analysis of carbohydrate polymers
IL152639A (en)	2008-03-20	Method and composition for analyzing a carbohydrate polymer
AU2002225992A1 (en)	2002-07-18	Methods for comparitive analysis of carbohydrate polymers
TWI390203B (zh)	2013-03-21	Thin film type carcass detection chip and its manufacturing method and use method
Campbell et al.	2011	Tools for glycomics: Glycan and lectin microarrays